Close intervention sessions complement intensive insulin therapy in paediatric diabetes: a longitudinal study

Arch Dis Child. 2023 Oct;108(10):818-823. doi: 10.1136/archdischild-2023-325436. Epub 2023 Jul 4.

Abstract

Objective: To examine the impact of multidisciplinary team input and intensive insulin therapy on glycaemic control in children and adolescents with diabetes over a 13-year period.

Design: Two statistical approaches were used to interrogate the dataset. First a matched pair analysis to compare insulin treatment-type effect (pump vs multiple daily injections (MDIs)), followed by panel data regression to assess the impact of intensive re-education on glycated haemoglobin (HbA1c), in addition to treatment type.

Setting: A large tertiary paediatric diabetes centre using a prospectively maintained database of clinical encounters from 2007 to 2020.

Main outcome measures: Difference in HbA1c between treatment types (matching methodology) and expected change in HbA1c with treatment type and re-education (panel data).

Results: Compared with MDI, matched pump patients had a lower HbA1c 6 months after pump commencement (ΔHbA1c=-0.53%, CI -0.34% to -0.72%; n=106). This effect was robust in controlling for socioeconomic deprivation (ΔHbA1c=-0.74%, CI -0.40% to -1.08%; n=29). Panel data analysis demonstrated a -0.55% reduction in HbA1c with pump therapy compared with MDI therapy (CI -0.43% to -0.67%). Patients who had intensive re-education had recorded an HbA1c of 0.95% (CI 0.85% to 1.05%) greater than otherwise identical patients prior to re-education. Following these sessions, HbA1c dropped by a mean -0.81% (CI -0.68% to -0.95%) within 6 months. These were also robust in controlling for socioeconomic factors.

Conclusions: Compared with matched peers on MDI regimens, patients on pump therapy have lower expected HbA1c, an effect sustained for up to 8 years. Intensive re-education is associated with a significant drop in previously elevated HbA1c levels.

Keywords: Endocrinology; Paediatrics; Statistics.

MeSH terms

  • Adolescent
  • Blood Glucose
  • Child
  • Diabetes Mellitus, Type 1* / drug therapy
  • Educational Status
  • Glycated Hemoglobin
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin Infusion Systems
  • Insulin* / therapeutic use
  • Longitudinal Studies

Substances

  • Insulin
  • Glycated Hemoglobin
  • Hypoglycemic Agents
  • Blood Glucose